ATE347546T1 - Hydroxyformamidin-derivate und diese enthaltende medikamente - Google Patents

Hydroxyformamidin-derivate und diese enthaltende medikamente

Info

Publication number
ATE347546T1
ATE347546T1 AT01941061T AT01941061T ATE347546T1 AT E347546 T1 ATE347546 T1 AT E347546T1 AT 01941061 T AT01941061 T AT 01941061T AT 01941061 T AT01941061 T AT 01941061T AT E347546 T1 ATE347546 T1 AT E347546T1
Authority
AT
Austria
Prior art keywords
group
formula
substituted
represented
participates
Prior art date
Application number
AT01941061T
Other languages
English (en)
Inventor
Masakazu Sato
Noriyuki Miyata
Takaaki Ishii
Yuko Kobayashi
Hideaki Amada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE347546T1 publication Critical patent/ATE347546T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01941061T 2000-06-15 2001-06-15 Hydroxyformamidin-derivate und diese enthaltende medikamente ATE347546T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000180479 2000-06-15
JP2000180477 2000-06-15
JP2000336140 2000-11-02
JP2000359781 2000-11-27

Publications (1)

Publication Number Publication Date
ATE347546T1 true ATE347546T1 (de) 2006-12-15

Family

ID=27481364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01941061T ATE347546T1 (de) 2000-06-15 2001-06-15 Hydroxyformamidin-derivate und diese enthaltende medikamente

Country Status (13)

Country Link
US (1) US6670382B2 (de)
EP (1) EP1291343B1 (de)
JP (1) JP4904659B2 (de)
KR (1) KR100776095B1 (de)
CN (1) CN1177824C (de)
AT (1) ATE347546T1 (de)
AU (2) AU2001274535B2 (de)
CA (1) CA2411418C (de)
DE (1) DE60125036T2 (de)
DK (1) DK1291343T3 (de)
ES (1) ES2280379T3 (de)
HK (1) HK1057043A1 (de)
WO (1) WO2001096309A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100776095B1 (ko) 2000-06-15 2007-11-15 다이쇼 세이야꾸 가부시끼가이샤 히드록시포름아미딘 유도체 및 이들을 포함하는 의약
JP4120401B2 (ja) 2001-04-26 2008-07-16 大正製薬株式会社 20−ヒドロキシエイコサテトラエン酸産生阻害剤
DE60218152T2 (de) * 2001-05-02 2007-12-06 Symbian Ltd. Gruppenkommunikationsverfahren für ein funkkommunikationsgerät
WO2003022821A1 (fr) * 2001-09-06 2003-03-20 Taisho Pharmaceutical Co., Ltd. Derive d'heterocycle presentant une activite inhibitrice de l'enzyme de production du 20-hete
AU2003262069A1 (en) 2002-09-12 2004-04-30 Taisho Pharmaceutical Co., Ltd. N-hydroxyformamidine derivative
ES2814200T3 (es) 2005-07-29 2021-03-26 Basf Se Estabilización de productos para el cuidado del cuerpo y del hogar contra la degradación por radiación UV utilizando derivados de merocianina
UA102514C2 (ru) * 2007-02-22 2013-07-25 Сингента Партисипейшнс Аг Производные иминопиридина, промежуточное соединение, способ борьбы с заражением полезных растений грибами или его предупреждение и композиция на основе производной иминопиридина
KR20180109871A (ko) * 2016-02-15 2018-10-08 다이쇼 세이야꾸 가부시끼가이샤 아졸로 치환된 피리딘 화합물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998970A (en) 1975-04-28 1976-12-21 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US3959368A (en) 1975-04-28 1976-05-25 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
GB1594261A (en) 1977-02-18 1981-07-30 Shell Int Research Benzyloxime ethers
US4079149A (en) 1977-06-30 1978-03-14 Shell Oil Company Benzyl oxime ethers
IL56878A (en) 1978-03-31 1984-03-30 Rhone Poulenc Inc Ketoximinoethers and their use as insecticides
US4158015A (en) 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
DE2907972A1 (de) 1979-03-01 1980-09-11 Bayer Ag Omega -halogen-acetophenon-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als zwischenprodukte zur herstellung von omega -azolyl-acetophenon-oximethern
IL60884A0 (en) 1979-08-24 1980-10-26 Mobil Oil Corp Ketoximinoethers and their use as insecticides
DE3005899A1 (de) 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
DE3044564A1 (de) 1980-11-26 1982-07-15 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von (alpha)-bromacetophenonoximethern
US4474815A (en) 1981-04-30 1984-10-02 Commonwealth Scientific And Industrial Research Organization Insecticidal oximes
US4566901A (en) 1982-05-06 1986-01-28 Ciba-Geigy Corporation Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof
US4434182A (en) 1982-11-01 1984-02-28 Fmc Corporation Insecticidal substituted-biphenylmethyl oxime ethers
IL75858A (en) 1984-07-31 1989-02-28 Commw Scient Ind Res Org Substituted benzyl ethers of oximes,their production and their use as arthropodicides
US4824476A (en) 1985-06-24 1989-04-25 Ciba-Geigy Corporation Herbicidally active derivatives of N-phenyl-3,4,5,6-tetrahydrophthalimide
DE4213149A1 (de) 1992-04-22 1993-10-28 Hoechst Ag Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US5267857A (en) 1993-02-12 1993-12-07 A-Dec, Inc. Brightness control system for dental handpiece light
DK1226819T3 (da) * 1999-11-01 2006-05-22 Taisho Pharmaceutical Co Ltd Inhibitor for 20-HETE-producerende enzym
KR100776095B1 (ko) 2000-06-15 2007-11-15 다이쇼 세이야꾸 가부시끼가이샤 히드록시포름아미딘 유도체 및 이들을 포함하는 의약
JP4120401B2 (ja) * 2001-04-26 2008-07-16 大正製薬株式会社 20−ヒドロキシエイコサテトラエン酸産生阻害剤

Also Published As

Publication number Publication date
JP4904659B2 (ja) 2012-03-28
KR100776095B1 (ko) 2007-11-15
HK1057043A1 (en) 2004-03-12
ES2280379T3 (es) 2007-09-16
US20030186979A1 (en) 2003-10-02
CN1177824C (zh) 2004-12-01
KR20030010690A (ko) 2003-02-05
DE60125036D1 (de) 2007-01-18
CA2411418A1 (en) 2002-12-06
CA2411418C (en) 2010-01-12
EP1291343B1 (de) 2006-12-06
US6670382B2 (en) 2003-12-30
AU2001274535B2 (en) 2005-06-30
EP1291343A4 (de) 2004-04-07
CN1436173A (zh) 2003-08-13
EP1291343A1 (de) 2003-03-12
DK1291343T3 (da) 2007-02-05
AU7453501A (en) 2001-12-24
WO2001096309A1 (fr) 2001-12-20
DE60125036T2 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
ATE288443T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
BRPI9908319B8 (pt) composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo.
EA200870384A1 (ru) 3,7-диамино-10h-фенотиазиновые соли и их применение
RS107504A (en) Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compostions including the same, and methods for their use
KR890012649A (ko) 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법
NO884202D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater.
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
IT1228293B (it) Benzoderivati di composti eterociclici contenenti azoto.
ATE347546T1 (de) Hydroxyformamidin-derivate und diese enthaltende medikamente
DE60137442D1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
ATE181918T1 (de) Purinderivate und ihre pharmazeutisch akzeptablen salze
KR910002818A (ko) 4,5,6,7-사치환된 벤즈옥사졸론
DE60119378T8 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
TH58670B (th) อนุพันธ์ 2-อะมิโน-3-(แอลคิล)-พิริมิโดน
TH84545B (th) สารรักษาโรค
TH84545A (th) สารรักษาโรค
TH62460A (th) ตัวยับยั้งเมทัลโลโพรทีเอสที่ได้รับการแทนที่ที่ n ซึ่งมีโซ่ข้างเฮเทอโรไซคลิค
IS7333A (is) MMP tálmar
TH51768A (th) สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว
TH84547A (th) สารรักษาโรค
TH84547B (th) สารรักษาโรค
TH52647B (th) วิธีสำหรับการบำบัดโรคนิโอแวสคิวละซึ่งมีผลต่อตา

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1291343

Country of ref document: EP